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| INTRODUC TI ON
Heart failure (HF) is defined as a clinical syndrome with impairment of blood ejection or ventricular filling (Yancy et al., 2013) . HF is a common cardiac problem which causes significant morbidity and mortality globally. It is estimated that up to twenty-three million people suffer from HF (McMurray, Petrie, Murdoch, & Davie, 1998) , and approximately half of patients would die within 5 years of diagnosis (Levy et al., 2002; Roger et al., 2004) . HF is mainly diagnosed on a clinical basis (Yancy et al., 2013) . Its risk factors include, but is not limited to, coronary heart disease, cigarette smoking, hypertension, obesity, diabetes, and valvular heart disease (He et al., 2001 ). Heart failure with reduced ejection fraction (HFrEF), a subgroup of HF with documented ejection fraction (EF) less than forty percent, has been a focus of clinical trials. Most studied pharmacologic and device therapies specifically demonstrated benefits only in this group of HF patients (Yancy et al., 2013) . Treatment of HFrEF includes lifestyle modification, management of underlying contributing factors, pharmacologic therapy, device therapy, cardiac rehabilitation, and preventive care. Several medications have been proven in their efficacy to reduce long-term morbidity and mortality. Device therapy has been recommended in stage C HF patients with strict indications and the risk and benefit should be thoroughly considered. Since the prognosis for HF varies widely, identifying patients at risk of poor clinical outcomes would be crucial. Several risk stratification tools or prognostic models have been proposed (Alba et al., 2013) . However, surface ECG parameters have not been widely developed in HF risk stratification, even though ECG is one of the most accessible tool and usually available in most healthcare settings.
Fragmented QRS (fQRS), which reflects myocardial scarring, has been found to be associated with poor prognostic outcome in several cardiac conditions, including coronary artery disease (Xu et al., 2015) , non-ischemic cardiomyopathy (Das et al., 2010) , Brugada syndrome (Rattanawong et al., 2017) , chronic total occlusion (Bonakdar et al., 2016) , and hypertrophic cardiomyopathy (Rattanawong et al., 2018) . Recent studies have demonstrated poor prognostic outcome in HFrEF patients whose baseline ECG was positive for fQRS.
However, the results were inconclusive and no meta-analysis has been performed. Hence, we conducted a systematic review of the literature and meta-analysis to assess prognostic value of fQRS in HFrEF patients.
| ME THODS

| Search strategy
We intended to identify all published reports relating the presence of fQRS and all-cause mortality or arrhythmic events in patients with HFrEF. The published studies indexed in EMBASE and MEDLINE databases from inception to February 2018 were independently searched by two investigators (PC and PM), supplemented by manual searches through the references of the publications. We used a search strategy that included fragmented QRS and heart failure.
Only English language publications involving human subjects were included.
| Inclusion criteria
The eligibility criteria included the following:
1. Cohort study (prospective or retrospective) or cross-sectional study reporting incidence or prevalence of all-cause mortality and major arrhythmic events (MAE), including ventricular fibrillation, sustained ventricular tachycardia, sudden cardiac arrest, or sudden cardiac death in heart failure with left ventricular dysfunction patients with and without baseline fQRS.
Heart failure with left ventricular dysfunction patients including
heart failure patients who have left ventricular EF ≤40% with or without implantable cardioverter-defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) for primary or secondary prevention, dilated cardiomyopathy (DCM), or ischemic cardiomyopathy (ICM) with follow-up period ≥6 months.
3.
Relative risk, hazard ratio, odds ratio, incidence ratio, or standardized incidence ratio with 95% confidence intervals (CI) or sufficient raw data for the calculation were provided.
4.
Participants without baseline fQRS were used as controls.
The studies that include patients described fQRS on vectorcardiography, magnetocardiography, or signal-averaged ECG were excluded.
Study eligibility was independently determined by two investigators (CK and PM) and differences were resolved by mutual consensus. Newcastle-Ottawa quality assessment scale was used to evaluate each study in three domains: recruitment and selection of the participants, similarity and comparability between the groups, and ascertainment of the outcome of interest among cohort studies (Table S1 ).
| Data extraction
We used a standardized data collection form to obtain information from each study as followed: title of study, name of the first author, year of study, year of publication, country of origin, number of subjects enrolled, demographic data, and average follow-up time.
To ensure accuracy of data, all investigators conducted a data extraction process independently. Should there was any data discrepancy, we referred to original articles.
K E Y W O R D S
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| Statistical analysis
We conducted a meta-analysis using random-effects model. We gathered the point estimates from each study by applying the generic in- 
| RE SULTS
| Description of included studies
Our search strategy generated ninety potentially relevant articles (fifty-four from EMBASE and thirty-eight from MEDLINE). Sixteen duplicated articles and two case reports were excluded, and 74 remaining articles underwent title and abstract review. Forty-nine studies were excluded by title and abstract review. Twenty-five remaining articles underwent full-length article review. Finally, seven retrospective cohorts, two prospective cohorts, and one cross-sectional study were included in the meta-analysis. Studies' characteristics are described in Table 1 . In one study (Pei et al., 2012) , we used the information from the subgroup analysis, since the characteristics of the subgroup fit with our criteria, while the characteristics of the main cohort did not.
| Quality assessment of included studies
We evaluated all included studies by using the Newcastle-Ottawa scale (zero-to-nine). The higher scores reflect higher study quality.
Three domains were considered; selection, comparability, and ascertainment of outcomes. Included studies' score ranged from 7 to 8, indicating their high quality. Intrastudy risks of bias, including population characteristics, outcome definitions and assessment, follow-up duration, loss during follow-up, and identified limitations, were individually assessed. No intrastudy risk of bias was identified (Table S1 ).
| Meta-analysis results
Ten studies were included into the meta-analysis. Nine of 10 studies
showed increased risk of all-cause mortality in patient with baseline fQRS. However, only one study (Cheema et al., 2010) showed nonsignificant negative association. Four cohorts from three studies showed significantly increased risk of all-cause mortality (Ozcan et al., 2013; Pei et al., 2012; Vandenberk et al., 2017 
| Subgroups analyses
| Ejection fraction
Subgroup analysis based on EF was performed to compare between HFrEF patient with EF < 35% and nonspecific EF (EF ≤ 40%).
Baseline fQRS significantly increased all-cause mortality and MAE 
| ICD status
In subgroup of patients who had not received ICD placement, baseline fQRS significantly increased all-cause mortality more than in patients who had received ICD placement (RR = 2.46 and 1.36, 95%
CI 1.56-3.89 and 1.08-1.71, respectively). Baseline fQRS increased MAE significantly in subgroup of patients who had not received ICD, but insignificantly in subgroup of patients who had received ICD (RR = 1.60 and 1.57, 95% CI 1.14-2.25 and 0.90-2.74, respectively).
| Ethnicities
Our analysis also indicated that baseline fQRS increased all-cause mortality in both Asian and Caucasian ethnicities (RR = 2.17 and 1.45, 95% CI 1.33-3.55 and 1.05-1.99, respectively). Baseline fQRS also increased MAE in Asian cohort (RR = 1.50, 95% CI 1.05-2.13).
Nonetheless, in Caucasian cohort, baseline fQRS did not significantly increase MAE (RR = 1.85, 95% CI 0.97-3.52).
| D ISCUSS I ON
This is the first meta-analysis to investigate the association between fQRS and prognostic outcomes in HFrEF patients. From included studies, most studies showed that fQRS was associated with increased all-cause mortality and increased MAE (Ahn, Kim, Joung, Lee, & Kim, 2013; Brenyo et al., 2012; Das et al., 2010; Forleo et al., 2011; Igarashi et al., 2017; Ozcan et al., 2013 Ozcan et al., , 2014 Pei et al., 2012; Sha et al., 2011; Vandenberk et al., 2017) , whereas one study revealed conflicting results (Cheema et al., 2010) . The meta-analysis demonstrated that baseline fQRS was associated with increased all-cause mortality in HFrEF patients up to 1.63-fold. We also found that fQRS increased MAE up to 1.74-fold. The result suggested that fQRS could potentially be integrated as a risk stratification tool in such patients to aid clinical decision. In this meta-analysis, we analyze fQRS regardless of its location. fQRS in inferior leads could be an independent predictor of SCD in CHF patients with ICM or DCM (Pei et al., 2012) . MADIT II study, which included patients with history of myocardial infarction within 1 month whose EF ≤ 30%, suggested a particularly strong association between inferior fQRS and SCD or appropriate ICD therapy (Brenyo et al., 2012) . Vandenberg et al. also reported a strong association between inferior fQRS and appropriate ICD therapy after implantation in patients receiving ICD for primary prevention of SCD (Vandenberk et al., 2017) . Nonetheless, there were not enough data to conclude related clinical outcomes regarding specific location of fQRS. Thus, largescale study is needed to warrant impact of fQRS in specific territory.
It is apparent that the association of fQRS and all-cause mortality was more pronounced in patients without ICD (2.46-fold when compared to 1.36-fold in patients with ICD). This could be accountable from beneficial effect of ICD to the patients who are susceptible to MAE resulting in dramatically decreased mortality.
The explanation of the pathophysiology of fQRS associated with major arrhythmic events and all-cause mortality is still unclear.
Recently, fQRS has been reported more in its prognostic effects of poor clinical outcomes in several cardiac conditions (Bonakdar et al., 2016; Das et al., 2010; Rattanawong et al., 2017; Xu et al., 2015) . Suggested mechanism of fQRS is explained by electrical dyssynchrony of interventricular conduction (Sinha et al., 2016) , which could result from a myocardial scar. Baseline fQRS was reported as a sensitive and specific tool to detect myocardial scars with sensitivity and specificity up to 85.6% and 89%, respectively (Das, Khan, Jacob, Kumar, & Mahenthiran, 2006; Sadeghi, Dabbagh, Tayyebi, Zakavi, & Ayati, 2016) .
Several prognostic models or scoring systems have been introduced to predict the outcomes from clinical data in HF patients. Nonetheless, they faced several challenges, especially their applicability and generalizability to HF patients in real clinical settings (Alba et al., 2013) . The Seattle Heart Failure Model (SHFM), which was proposed in 2006, was developed based on a database of 1,125 patients in the PRAISE clinical trial (Levy et al., 2006) . The recruited patients in the trial were limited to patients in the United
States and Canada with ejection <30% with the New York Heart Association classification functional class IIIB to IV heart failure thus external validity of the study was relatively limited. Published in 2012, the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) from 39,372 patients in 30 studies proposed the score based on 13 independent predictors of mortality in HF patients (Pocock et al., 2013) . These predictors, by the order of predictive strength, included age, lower EF, the New York Heart Association classification, serum creatinine, diabetic status, not-prescribed beta-blocker, lower systolic BP, lower body mass, time since diagnosis, current smoker, chronic obstructive pulmonary disease, male gender, and having not being prescribed with ACE-inhibitors or angiotensin-receptor blockers (Pocock et al., 2013) . Several other models were developed to predict outcomes in patients with acute decompensated heart failure (Passantino, Monitillo, Iacoviello, & Scrutinio, 2015) or chronic heart failure-yet, none have become standard in clinical practice. This stressed the complexity in predicting outcome and the necessity to develop practical and widely applicable tools, and surface ECG clues could potentially be integrated into those prognostic predictors.
| LI M ITATI O N S
There are a few limitations in our study. 
| CON CLUS ION
Our study suggests that fQRS is significantly associated with increased all-cause mortality and MAE in HFrEF patients. Hence, fQRS could be considered as a potential element in risk stratification of HF patients. Since HFrEF patients are relatively heterogeneous, further
F I G U R E 1 Search methodology and selection process
Potential relevant articles identified from search of MEDLINE (n = 38) and EMBASE database (n = 54) and screened for retreival 25 articles underwent full-length article review 15 articles were excluded at this stage as they were -1 study of paced fragmented QRS -1 study of alternative definition of fQRS -9 conducted in patients with LVEF>40% -3 without mortality or arrhythmic endpoint data -1 with insufficient data 49 articles excluded by title and abstract review 10 articles underwent meta-analysis
Title and abstract review of potentially relevant articles (n = 74) 16 duplications excluded 2 case reports excluded F I G U R E 2 All-cause mortality (main result)
F I G U R E 3 Major arrhythmic events (main result)
F I G U R E 4 All-cause mortality and major arrhythmic event (subgroup analysis by EF)
F I G U R E 5 All-cause mortality and major arrhythmic event (subgroup analysis by ethnicities) studies would be needed to validate its role in risk stratifying HFrEF
